1. Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme.
- Author
-
Musacchio, N., Scher, A. Lovagnini, Giancaterini, A., Pessina, L., Salis, G., Schivalocchi, F., Nicolucci, A., Pellegrini, F., and Rossi, M. C. E.
- Subjects
- *
ANTIHYPERTENSIVE agents , *ANTILIPEMIC agents , *BLOOD pressure , *COMPUTER software , *CONFIDENCE intervals , *DECISION making , *DIABETES , *GLYCOSYLATED hemoglobin , *LONGITUDINAL method , *LOW density lipoproteins , *METABOLIC regulation , *TYPE 2 diabetes , *HEALTH outcome assessment , *PATIENT education , *LEGAL status of patients , *REGRESSION analysis , *HEALTH self-care , *SELF-efficacy , *STATISTICAL hypothesis testing , *DATA analysis , *TREATMENT effectiveness , *PRE-tests & post-tests , *REPEATED measures design , *EVALUATION of human services programs - Abstract
Aims Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano-Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1c without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently. Methods Clinical outcomes measured in the year before and after the initiation of SINERGIA were compared. A generalized hierarchical linear regression model for repeated measures was used. Results Altogether, 1004 patients were included; baseline characteristics were (mean ± SD): age 66.6 ± 6.2 years, 54.1% male, diabetes duration 10.8 ± 7.7 years, BMI 29.5 ± 4.8 kg /m², HbA1c 6.9 ± 0.9% (52 ± 14 mmol/ mol); 72.9% of patients were treated with anti-hypertensive drugs; 32.7%were treated with lipid-lowering drugs. After a median follow-up of 12 months (range 6-24 months), the proportion of patients with HbA1c ≤ 7.0% (≤ 53 mmol/mol) increased from 32.7 to 45.8%(P < 0.0001), while those with HbA1c ≥ 9%(≥ 75 mmol/mol) decreased from 10.5 to 4.3%(P < 0.0001). Patients with LDL cholesterol < 100 mg/dl (< 2.59 mmol/l) increased from 40 to 47% (P < 0.0001), while those with LDL cholesterol ≥ 130 mg/dl (≥ 3.36 mmol/l) decreased from 26.6 to 19.7%; blood pressure levels were slightly improved. The mean number of face-to-face encounters decreased from (median and range) 2.8 (2.3-3.4) to 2.3 (1.9-2.7) (P < 0.0001) visits per patient/year. Conclusions The SINERGIA model is effective in improving metabolic control and major cardiovascular risk factors, while allowing diabetologists to dedicate more time to patients with more acute disease. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF